SEARCH

SEARCH BY CITATION

References

  • 1
    Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011;123:e18e209.
  • 2
    McGillion M, Arthur H, Andrell P, et al. Self management training in refractory angina. BMJ. 2008;336:338339.
  • 3
    Arora RR, Chou TM, Jain D, et al. The Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:18331840.
  • 4
    Masuda D, Nohara R, Hirai T, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Eur Heart J. 2001;22:14511458.
  • 5
    Stys TP, Lawson WE, Hui JCK, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002;89:822824.
  • 6
    Pettersson T, Bondesson S, Cojocaru D, et al. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation. BMC Cardiovasc Disord. 2006;6:28.
  • 7
    Arora RR, Chou TM, Jain D, et al. Effects of enhanced external counterpulsation on health-related quality of life continue 12 months after treatment: a substudy of the multicenter study of enhanced external counterpulsation. J Investig Med. 2002;50:2532.
  • 8
    Michaels AD, Linnemeier G, Soran O, et al. Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). Am J Cardiol. 2004;93:461464.
  • 9
    Lawson WE, Hui JCK, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol. 2000;23:254258.
  • 10
    Loh PH, Cleland JG, Louis AA, et al. 2008. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol. 2008;31:159164.
  • 11
    Soran O, Kennard ED, Kfoury AG, et al; IEPR Investigators. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Am J Cardiol. 2006;97:1720.
  • 12
    Braverman DL. Enhanced external counterpulsation: an innovative physical therapy for refractory angina. PM R. 2009;1:268276.
  • 13
    Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111:33163326.
  • 14
    Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echo-cardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:12201225.
  • 15
    Stewart B, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630634.
  • 16
    Helske S, Kupari M, Lindstedt KA, et al. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol. 2007;18:483491.
  • 17
    Braith RW, Conti CR, Nichols WW, et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010;122:16121620.
  • 18
    Stys T, Lawson WE, Hui JC, et al. Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology. 2001;52:653658.
  • 19
    Barsness G, Feldman AM, Holmes DR Jr, et al. International EECP patient registry (IEPR); design, methods, baseline characterization and acute results. Clin Cardiol. 2001;24:435442.
  • 20
    Novo G, Bagger JP, Carta R, et al. Enhanced External counterpulsation for treatment of refractory angina pectoris. J Cardiovasc Med. 2006;7:335339.
  • 21
    Loh PH, Louis AA, Windram J, et al. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina. J Intern Med. 2006;259:276284.
  • 22
    Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anethesiologists, Society for Cardiovascular Angiography and Intervetions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1e142.
  • 23
    Bourma BJ, van Den Brink RB, van Der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart. 1999;82:4348.
  • 24
    Ambler G, Ovar RZ, Royston P, et al. Generic, simple risk stratification model for heart valve surgery. Circulation. 2005;112:224231.
  • 25
    Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50:20182019.
  • 26
    Rapp AH, Hillis LD, Lange RA, et al. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol. 2001;87:12161217.
  • 27
    Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679688.
  • 28
    Julius BK, Spillmann M, Vassalli G, et al. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation. 1997;95:892898.
  • 29
    Michaels AD, Accad M, Ports TA, et al. Left ventricular systolic unloading and augmentation of intracoronary pressure and doppler flow during enhanced external counterpulsation. Circulation. 2002;106:12371242.
  • 30
    Kemper AJ, Khuri SF, Josa M, et al. Intraaortic balloon counterpulsation as a temporary support measure in decompensated critical aortic stenosis. J Am Coll Cardiol. 1985;5:711716.
  • 31
    Aksoy O, Yousefzai R, Singh D, et al. Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support. Heart. 2011;97:838843.
  • 32
    Vasomedical, Inc. Web site. EECP Therapy Patient Selection Precautions. http://www.eecp.com/patient-selection.php. Accessed October 15, 2012.
  • 33
    Eftekhari A, May O. The immediate hemodynamic effects of enhanced external counterpulsation on the left ventricular function. Scand Cardiovasc J. 2012;46:8186.
  • 34
    Suresh K, Simandi S, Lawson WE, et al. Maximizing the hemodynamic benefit of enhanced external counterpulsation. Clin Cardiol. 1998;21:649653.
  • 35
    Michaels Ad, Kennard ED, Kelsey SE, et al. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation (EECP)? Data from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol. 2001:24:453458.
  • 36
    Lakshmi MV, Kennard ED, Kelsey SF, et al. Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry [IEPR]). Am J Cardiol. 2002;89: 13031305.
  • 37
    Campbell AR, Satran D, Zenovich AG, et al. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina. Am Heart J. 2008;156:12171222.
  • 38
    Karia DH, Haq N, Huda N, et al. Enhanced external counterpulsation (EECP) is very effective in reducing blood pressure in hypertensive subjects. CVD Prev Control. 2009;4(suppl 1): S160.
  • 39
    Lawson WE, Hui JCK, Kennard ED, et al. Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation. Clin Cardiol. 2006;29:6973.
  • 40
    Lawson WE, Hui JCK, Zheng ZS, et al. Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol. 1995;75:840841.